Arrhythmia News and Research

RSS
An arrhythmia is a problem with the speed or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. A heartbeat that is too fast is called tachycardia. A heartbeat that is too slow is called bradycardia. Most arrhythmias are harmless, but some can be serious or even life threatening. When the heart rate is too slow, too fast, or irregular, the heart may not be able to pump enough blood to the body. Lack of blood flow can damage the brain, heart, and other organs.
QT Medical partners with LA BioMed to identify infants at risk of long QT syndrome

QT Medical partners with LA BioMed to identify infants at risk of long QT syndrome

French hospital uses Sophia DDM Platform to improve diagnostic testing of congenital disorders

French hospital uses Sophia DDM Platform to improve diagnostic testing of congenital disorders

ECMO improves survival, neurological outcomes in patients suffering from cardiac arrest

ECMO improves survival, neurological outcomes in patients suffering from cardiac arrest

High doses of fish oil supplements do not reduce atrial fibrillation

High doses of fish oil supplements do not reduce atrial fibrillation

Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Cardiac arrhythmias pose risk in pulmonary hypertension patients

Cardiac arrhythmias pose risk in pulmonary hypertension patients

Increasing prevalence of obstructive sleep apnea threatens public health and safety

Increasing prevalence of obstructive sleep apnea threatens public health and safety

New AliveECG app provides patients with free real-time AF detection in ECG recordings

New AliveECG app provides patients with free real-time AF detection in ECG recordings

RDT receives FDA clearance for Tempus Pro advanced medical monitor

RDT receives FDA clearance for Tempus Pro advanced medical monitor

New evidence-based guidelines for prevention, treatment of POAF

New evidence-based guidelines for prevention, treatment of POAF

RT with concurrent chemotherapy post surgery is effective for treating endometrial cancer

RT with concurrent chemotherapy post surgery is effective for treating endometrial cancer

Mice who have partial deficiency of gene SENP2 are more likely to develop seizures, sudden death

Mice who have partial deficiency of gene SENP2 are more likely to develop seizures, sudden death

Simple awareness campaign in general practice helps improve early diagnosis of AF

Simple awareness campaign in general practice helps improve early diagnosis of AF

Permanent atrial fibrillation twins risk of stroke than paroxysmal AF

Permanent atrial fibrillation twins risk of stroke than paroxysmal AF

Study suggests that energy drinks can cause heart problems

Study suggests that energy drinks can cause heart problems

Novel document on ventricular arrhythmias published in EP Europace

Novel document on ventricular arrhythmias published in EP Europace

Recommendations on arrhythmia management in ACS patients published in EP Europace

Recommendations on arrhythmia management in ACS patients published in EP Europace

FDA approves AliveCor algorithm for detecting AFib through ECG recordings on mobile phone

FDA approves AliveCor algorithm for detecting AFib through ECG recordings on mobile phone

Study sheds new light on how carbon monoxide could help protect hearts against arrhythmias

Study sheds new light on how carbon monoxide could help protect hearts against arrhythmias

Researchers examine impact of extreme temperatures on number of deaths

Researchers examine impact of extreme temperatures on number of deaths

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.